The age at which psoriasis first appears can be an important predictor for the transition to psoriatic arthritis.
Read MoreCase Report: Dermatomyositis and Malignancy
Watch as Juliette Yedimenko, MD, discusses a case in which a dermatomyositis flare led to the discovery of a müllerian carcinoma.
Family History of Psoriasis and Acute Psychological Stress Are Associated With the Development of TNFI-Induced Psoriasis
Despite 15 years of experience with tumor necrosis factor -α inhibitor (TNFI) -induced psoriasis, our understanding of its pathogenesis remains incomplete. A recent case-control study identified risk factors and triggers associated with the onset of this condition.
Clinical Characteristics of Sarcoidosis in an Asian Population
Ethnicity influences the epidemiology and clinical phenotype of sarcoidosis; however, data on clinical manifestations of sarcoidosis in Asians are relatively limited. In this article, rheumatologist Patompong Ungprasert, MD, discusses the results of a 14-year, single center study from Thailand.
Chronic Glucocorticoid Use Found to Be 5x More Likely in Black Patients With Systemic Lupus Erythematosus
Data analysis reveals that Black patients with systemic lupus erythematosus (SLE) are 5x more likely to use chronic glucocorticoids than white patients. Healthcare access may play a role.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Hand Contractures and Skin Nodules in a 66-Year-Old Woman
Diagnosis of fibroblastic rheumatism is based on characteristic clinical findings in combination with histopathological findings. This case study illustrates the differential diagnosis, and reviews imaging and laboratory findings.
Collaborative Rheumatology-Dermatology Clinic Improves Outcomes
Co-management clinics yield improved patient outcomes and increased opportunities for research and education. In this article, rheumatologist Elaine Husni, MD, MPH, and dermatologist Anthony Fernandez, MD, PhD, discuss their new shared clinic.
Balancing the Benefits of Biologic Therapy for Autoimmune Disease Against the Risks of Mycobacterial Infections
Tumor necrosis factor-α inhibitors (TNFis) have transformed care for rheumatoid arthritis and other autoimmune diseases, but they also are associated with higher risks of serious and opportunistic infections than traditional disease-modifying antirheumatic drugs. In this article, Cassandra Calabrese, DO, discusses balancing the benefits of biologic therapies with the risks of infection.
Extremely Rare Association of Anti-PM-Scl Antibody-Associated Systemic Sclerosis and Inclusion Body Myositis
Two female patients with anti-PM-Scl antibody-associated systemic sclerosis developed progressive proximal myopathy. Both patients had profound muscle weakness that was refractory to treatment with glucocorticoids with or without other oral immunosuppressants. In this article, rheumatologist Souyma Chatterjee, MD, shares two cases of anti-PM-Scl antibody-associated scleromyositis in which a muscle biopsy unexpectedly showed features of sporadic inclusion body myositis.
Polymyalgia Rheumatica-Like Syndrome from Checkpoint Inhibitor Therapy
Is checkpoint inhibitor-related polymyalgia rheumatica (PMR) distinct from the classic rheumatic disease, or does it represent new clinical variants with potentially different pathogenesis, clinical course and treatment responsiveness? Rheumatologist/immunologist Cassandra Calabrese, DO, discusses her research, which identified clinical features that are unusual in idiopathic PMR.
Systemic Sclerosis: Critical Digital Ischemia with Acro-Osteolysis
A 58‐year‐old female with an 18‐year history of limited cutaneous systemic sclerosis presents with severe pain and ulceration affecting the tips of her fingers. On examination, there was evidence of auto‐amputation of some of her distal phalanges and ulceration of the overlying skin. What’s the diagnosis?